SUVRETTA CAPITAL MANAGEMENT, LLC - Q4 2021 holdings

$5.16 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 48.1% .

 Value Shares↓ Weighting
AMZN BuyAMAZON COM INC$360,209,000
+10.6%
108,030
+9.0%
6.97%
+27.1%
MSFT NewMICROSOFT CORP$290,917,000865,000
+100.0%
5.63%
UNH SellUNITEDHEALTH GROUP INC$229,373,000
-17.9%
456,790
-36.1%
4.44%
-5.7%
ADBE SellADOBE SYSTEMS INCORPORATED$222,405,000
-39.1%
392,207
-38.2%
4.31%
-30.1%
OTIS SellOTIS WORLDWIDE CORP$216,332,000
-2.6%
2,484,580
-8.0%
4.19%
+11.9%
UNP SellUNION PAC CORP$203,564,000
+26.7%
808,020
-1.4%
3.94%
+45.6%
TPR SellTAPESTRY INC$184,627,000
-7.3%
4,547,460
-15.4%
3.58%
+6.6%
TMO SellTHERMO FISHER SCIENTIFIC INC$180,468,000
-3.0%
270,470
-17.0%
3.49%
+11.4%
GFL SellGFL ENVIRONMENTAL INC$175,133,000
-0.0%
4,627,040
-1.9%
3.39%
+14.9%
EL SellLAUDER ESTEE COS INCcl a$166,353,000
+8.0%
449,360
-12.5%
3.22%
+24.2%
ABC BuyAMERISOURCEBERGEN CORP$165,290,000
+12.1%
1,243,810
+0.7%
3.20%
+28.8%
IQV SellIQVIA HLDGS INC$157,931,000
-6.2%
559,760
-20.4%
3.06%
+7.8%
ADI BuyANALOG DEVICES INC$144,010,000
+80.0%
819,310
+71.5%
2.79%
+106.8%
RH SellRH$133,942,000
-40.0%
249,920
-25.4%
2.59%
-31.1%
PWR SellQUANTA SVCS INC$133,351,000
-15.6%
1,163,015
-16.3%
2.58%
-3.0%
MNST NewMONSTER BEVERAGE CORP NEW$109,841,0001,143,700
+100.0%
2.13%
CVNA SellCARVANA COcl a$99,161,000
-31.4%
427,807
-10.7%
1.92%
-21.1%
HLT NewHILTON WORLDWIDE HLDGS INC$93,441,000599,022
+100.0%
1.81%
OPEN SellOPENDOOR TECHNOLOGIES INC$90,129,000
-53.5%
6,168,996
-34.7%
1.74%
-46.6%
MA SellMASTERCARD INCORPORATEDcl a$89,927,000
-61.6%
250,270
-62.9%
1.74%
-55.9%
CANO BuyCANO HEALTH INC$87,968,000
-17.6%
9,872,990
+17.3%
1.70%
-5.3%
ALIT SellALIGHT INC$84,426,000
-11.9%
7,810,000
-6.5%
1.64%
+1.2%
MAR NewMARRIOTT INTL INC NEWcl a$81,569,000493,640
+100.0%
1.58%
DECK NewDECKERS OUTDOOR CORP$79,207,000216,230
+100.0%
1.53%
RPRX BuyROYALTY PHARMA PLC$78,396,000
+42.0%
1,967,273
+28.8%
1.52%
+63.2%
DHR NewDANAHER CORPORATION$72,448,000220,200
+100.0%
1.40%
SQ BuyBLOCK INCcl a$69,447,000
-4.4%
429,984
+41.9%
1.34%
+9.9%
ITCI  INTRA-CELLULAR THERAPIES INC$65,527,000
+40.4%
1,251,9460.0%1.27%
+61.5%
TEL SellTE CONNECTIVITY LTD$61,732,000
-25.5%
382,623
-36.6%
1.20%
-14.4%
NTRA SellNATERA INC$59,411,000
-28.7%
636,160
-14.9%
1.15%
-18.0%
MRTX BuyMIRATI THERAPEUTICS INC$59,085,000
+74.6%
402,789
+110.5%
1.14%
+100.7%
NewRIVIAN AUTOMOTIVE INC$52,657,000507,830
+100.0%
1.02%
KURA BuyKURA ONCOLOGY INC$50,014,000
+8.5%
3,572,419
+45.2%
0.97%
+24.7%
CPRT SellCOPART INC$46,244,000
-61.8%
305,000
-65.1%
0.90%
-56.1%
FULC BuyFULCRUM THERAPEUTICS INC$42,024,000
-23.3%
2,375,571
+22.3%
0.81%
-11.8%
RARE NewULTRAGENYX PHARMACEUTICAL IN$40,804,000485,242
+100.0%
0.79%
AGIO SellAGIOS PHARMACEUTICALS INC$38,700,000
-36.1%
1,177,374
-10.2%
0.75%
-26.6%
STRO BuySUTRO BIOPHARMA INC$36,274,000
-14.0%
2,437,795
+9.1%
0.70%
-1.3%
SellWARBY PARKER INC$34,147,000
-35.6%
733,402
-26.7%
0.66%
-26.1%
KBR SellKBR INC$32,644,000
-72.2%
685,500
-77.0%
0.63%
-68.1%
BuyMARINUS PHARMACEUTICALS INC$31,349,000
+25.4%
2,638,775
+20.1%
0.61%
+44.2%
EYPT BuyEYEPOINT PHARMACEUTICALS INC$30,841,000
+73.6%
2,519,700
+47.8%
0.60%
+99.7%
INSM BuyINSMED INC$29,461,000
+7.1%
1,081,532
+8.3%
0.57%
+23.1%
ETSY NewETSY INC$26,745,000122,158
+100.0%
0.52%
MQ NewMARQETA INC$25,195,0001,467,368
+100.0%
0.49%
KZR  KEZAR LIFE SCIENCES INC$23,574,000
+93.5%
1,409,9560.0%0.46%
+122.4%
KALV BuyKALVISTA PHARMACEUTICALS INC$23,104,000
-14.2%
1,746,300
+13.2%
0.45%
-1.5%
ARNA SellARENA PHARMACEUTICALS INC$22,845,000
-24.3%
245,800
-51.5%
0.44%
-13.2%
HRTX BuyHERON THERAPEUTICS INC$22,700,000
+42.5%
2,486,340
+66.8%
0.44%
+63.8%
XENE SellXENON PHARMACEUTICALS INC$21,618,000
+22.1%
692,000
-40.3%
0.42%
+40.6%
KDNY BuyCHINOOK THERAPEUTICS INC$20,346,000
+52.2%
1,247,468
+19.1%
0.39%
+75.1%
CHRS BuyCOHERUS BIOSCIENCES INC$19,452,000
+147.4%
1,218,792
+149.1%
0.38%
+185.6%
CMRX BuyCHIMERIX INC$17,789,000
+50.7%
2,766,619
+45.0%
0.34%
+72.9%
IFRX  INFLARX NV$15,637,000
+83.8%
3,285,0000.0%0.30%
+111.9%
PNT BuyPOINT BIOPHARMA GLOBAL INC$14,968,000
-12.5%
2,672,863
+20.1%
0.29%
+0.7%
MREO  MEREO BIOPHARMA GROUP PLCads$14,627,000
-33.9%
9,142,0670.0%0.28%
-24.1%
NewGRAB HOLDINGS LIMITEDclass a ord$14,260,0002,000,000
+100.0%
0.28%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$12,212,000
-28.8%
2,571,000
+19.2%
0.24%
-18.3%
PHVS NewPHARVARIS N V$11,908,000827,540
+100.0%
0.23%
SLDB BuySOLID BIOSCIENCES INC$11,003,000
-22.9%
6,287,193
+5.2%
0.21%
-11.6%
BOLT BuyBOLT BIOTHERAPEUTICS INC$10,928,000
-34.8%
2,230,250
+68.3%
0.21%
-25.1%
 DICE THERAPEUTICS INC$10,377,000
-22.7%
410,0000.0%0.20%
-11.1%
AMAM NewAMBRX BIOPHARMA INCsponsored ads$9,551,0001,057,735
+100.0%
0.18%
TERN BuyTERNS PHARMACEUTICALS INC$8,758,000
-25.3%
1,238,800
+10.0%
0.17%
-14.1%
MOLN  MOLECULAR PARTNERS AGads$7,672,000
-2.2%
400,0000.0%0.15%
+12.9%
SIOX BuySIO GENE THERAPIES INC$7,629,000
-35.9%
5,914,000
+7.7%
0.15%
-26.4%
INZY BuyINOZYME PHARMA INC$6,910,000
-39.6%
1,013,216
+2.7%
0.13%
-30.6%
GMTX BuyGEMINI THERAPEUTICS INC$6,903,000
-20.1%
2,372,267
+11.0%
0.13%
-8.2%
NewROIVANT SCIENCES LTD$6,870,000681,528
+100.0%
0.13%
ORIC BuyORIC PHARMACEUTICALS INC$6,478,000
+107.8%
440,696
+195.6%
0.12%
+135.8%
MIST  MILESTONE PHARMACEUTICALS IN$5,576,000
+14.7%
851,2910.0%0.11%
+31.7%
OTIC BuyOTONOMY INC$5,570,000
+21.5%
2,678,115
+12.2%
0.11%
+40.3%
ABCL NewABCELLERA BIOLOGICS INCcall$5,250,000367,100
+100.0%
0.10%
RACB  RESEARCH ALLIANCE CORP II$4,885,000
-0.8%
500,0000.0%0.10%
+14.5%
ALLO NewALLOGENE THERAPEUTICS INC$3,956,000265,116
+100.0%
0.08%
 NUVALENT INC$3,808,000
-15.6%
200,0000.0%0.07%
-2.6%
 IMMUNEERING CORP$3,234,000
-39.1%
200,0000.0%0.06%
-29.2%
OMEG  OMEGA ALPHA SPACcl a$2,931,000
+0.3%
300,0000.0%0.06%
+16.3%
EBAC  EUROPEAN BIOTECH ACQUTN CORP$2,907,000
+0.2%
300,0000.0%0.06%
+14.3%
NewOPY ACQUISITION CORP Iunit 09/22/2026$2,000,000200,000
+100.0%
0.04%
BNTC  BENITEC BIOPHARMA INC$2,015,000
-26.6%
769,0000.0%0.04%
-15.2%
BLSA  BCLS ACQUISITION CORP$1,960,000
-1.6%
200,0000.0%0.04%
+11.8%
TMPM  TURMERIC ACQUISITION CORPcl a$1,964,000
+0.3%
200,0000.0%0.04%
+15.2%
NewENTRADA THERAPEUTICS INC$1,815,000106,000
+100.0%
0.04%
CANOWS  CANO HEALTH INC*w exp 06/03/202$1,612,000
-42.1%
674,5660.0%0.03%
-34.0%
DBTX  DECIBEL THERAPEUTICS INC$1,226,000
-39.7%
263,6000.0%0.02%
-29.4%
EUCR  EUCRATES BIOMEDICAL ACQU COR$976,000
-0.2%
99,9990.0%0.02%
+18.8%
FLAC  FRAZIER LIFESCIENCES ACQU CO$853,000
-0.7%
87,4980.0%0.02%
+21.4%
MGTX NewMEIRAGTX HLDGS PLC$821,00034,600
+100.0%
0.02%
SRNE NewSORRENTO THERAPEUTICS INC$492,000105,744
+100.0%
0.01%
FSRXW  FINSERV ACQUISITION CORP II*w exp 02/17/202$169,000
-30.5%
273,1490.0%0.00%
-25.0%
EBACW  EUROPEAN BIOTECH ACQUTN CORP*w exp 03/06/202$60,000
-3.2%
100,0000.0%0.00%0.0%
TMPMW  TURMERIC ACQUISITION CORP*w exp 10/08/202$45,000
-2.2%
66,6660.0%0.00%0.0%
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$19,000
-20.8%
33,3330.0%0.00%
FLACW  FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202$17,000
-15.0%
29,1660.0%0.00%
SYBX ExitSYNLOGIC INC$0-60,000
-100.0%
-0.00%
ADAG ExitADAGENE INCads$0-42,722
-100.0%
-0.01%
FHTX ExitFOGHORN THERAPEUTICS INC$0-84,000
-100.0%
-0.02%
NAUT ExitNAUTILUS BIOTECHNOLOGY INC$0-314,835
-100.0%
-0.03%
ALITWS ExitALIGHT INC*w exp 05/26/202$0-774,375
-100.0%
-0.04%
ExitVOLTA INC$0-300,000
-100.0%
-0.04%
HCAQ ExitHEALTHCOR CATALIO ACQU CORP$0-300,000
-100.0%
-0.05%
FSII ExitFS DEVELOPMENT CORP II$0-400,000
-100.0%
-0.07%
MAAC ExitMONTES ARCHIMEDES ACQUISITIO$0-500,000
-100.0%
-0.08%
NEXI ExitNEXIMMUNE INC$0-344,223
-100.0%
-0.09%
ExitFRESHWORKS INC$0-150,000
-100.0%
-0.11%
ACIU ExitAC IMMUNE SA$0-963,500
-100.0%
-0.11%
ExitARCHER AVIATION INC$0-750,000
-100.0%
-0.11%
ExitNERDY INC$0-700,000
-100.0%
-0.12%
ExitEVOLV TECHNOLOGIES HLDNGS IN$0-1,367,870
-100.0%
-0.14%
BCAB ExitBIOATLA INC$0-354,190
-100.0%
-0.18%
FSRX ExitFINSERV ACQUISITION CORP II$0-1,092,600
-100.0%
-0.18%
RXDX ExitPROMETHEUS BIOSCIENCES INC$0-480,480
-100.0%
-0.19%
ExitCAZOO GROUP LTD$0-1,509,700
-100.0%
-0.20%
ExitROCKET LAB USA INC$0-750,000
-100.0%
-0.20%
FREY ExitFREYR BATTERY$0-2,093,710
-100.0%
-0.35%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-862,126
-100.0%
-0.49%
ESTC ExitELASTIC N V$0-271,000
-100.0%
-0.68%
NXPI ExitNXP SEMICONDUCTORS N V$0-256,438
-100.0%
-0.85%
MA ExitMASTERCARD INCORPORATEDcall$0-172,600
-100.0%
-1.01%
HWM ExitHOWMET AEROSPACE INC$0-2,551,230
-100.0%
-1.34%
PTON ExitPELOTON INTERACTIVE INC$0-1,166,800
-100.0%
-1.71%
MDT ExitMEDTRONIC PLC$0-911,226
-100.0%
-1.92%
ROST ExitROSS STORES INC$0-1,117,935
-100.0%
-2.05%
PLAN ExitANAPLAN INC$0-2,165,238
-100.0%
-2.22%
TWLO ExitTWILIO INCcl a$0-516,520
-100.0%
-2.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings